Sep. 3, 2013 Ground-breaking new research from a team of evolutionary biologists at Indiana University shows for the first time how asexual lineages of a species are doomed not necessarily from a long, slow accumulation of new mutations, but rather from fast-paced gene conversion processes that simply unmask pre-existing deleterious recessive mutations.

Geneticists have long bet on the success of sexual reproduction over asexual reproduction based in a large part on the process known as Muller's ratchet, the mechanism by which a genome accrues deleterious and irreversible mutations after the host organism has lost its ability to carry out the important gene-shuffling job of recombination.

The new work from the laboratory of IU Distinguished Professor of Biology Michael Lynch instead indicates that most deleterious DNA sequences contributing to the extinction process are actually present in the sexual ancestors, albeit in recessive form, and simply become exposed via fast-paced gene conversion and deletion processes that eliminate the fit genes from one of the parental chromosomes.

After sequencing the entire genomes of 11 sexual and 11 asexual genotypes of Daphnia pulex, a model organism for the study of reproduction that is more commonly known as the water flea, the team discovered that every asexual genotype shared common combinations of alleles for two different chromosomes transmitted by asexual males without recombination.

Asexual males then spread the genetic elements for suppressing meiosis, the type of cell division necessary for sexual reproduction, into sexual populations. The unique feature of this system is that although females become asexual, their sons need not be, and instead have the ability to spread the asexuality gene to sexual populations -- in effect, by a process of contagious asexuality.

"One might think of this process as a transmissible asexual disease," Lynch said. Exposure of pre-existing, deleterious alleles is, incidentally, a major cause of cancer, he added.

In another remarkable finding from the genome-wide survey for asexual markers, the team was also able to determine the age of the entire asexual radiation for D. pulex. Just a few years ago biologists were guessing that asexual daphnia lineages could be millions of years old, and most recent estimates put it between 1,000 years and 172,000 years. But new calculations for the molecular evolutionary rates of the two chromosomes implicated in asexuality date the establishment and spread of the asexual lineage to just 1,250 years ago. Some current asexual lineages, in fact, were only decades old, younger than Lynch himself.

"A pond of asexual daphnia may go extinct quite rapidly owing to these deleterious-gene-exposing processes, but the small chromosomal regions responsible for asexuality survive by jumping to new sexual populations where they again transform the local individuals to asexuality by repeated backcrossing," Lynch said. "Soon after such a transformation, the processes of gene conversion and deletion restarts, thereby again exposing resident pre-existing mutations leading to another local extinction event. As far as the sexual populations are concerned, asexuality is infectious, spreading across vast geographic distances while undergoing no recombination."

Lynch said it remains unclear what the ultimate fate of the entire sexual species will be and whether all sexual populations will be eventually displaced by the westward march of asexual lineages.

The team from the IU College of Arts and Sciences' Department of Biology used sexual and asexual daphnia sourced from ponds and lakes in six states and two Canadian provinces. The new work supported past research showing that a westward expansion of asexual lineages began in northeastern North America.

Continue reading here:
Death by asexuality: Biologists uncover new path for mutations to arise

Recommendation and review posted by Bethany Smith

Think tank calls for GE-free farming

Media release 3 September 2013 FOR IMMEDIATE RELEASE

A Wellington think tanks call for New Zealand to be a GE-free food and fibre producer has been welcomed by the Soil & Health Association. The latest McGuinness Institute report, An Overview of Genetic Modification in New Zealand, 19732013 was released on 29 August.

This comprehensive and thoroughly researched report sums up a lot of what weve been saying for years, says Marion Thomson, co-chair of Soil & Health Organic NZ. Soil & Health agrees with its recommendations, including a moratorium on growing genetically engineered crops, and a thorough review of the systems and policy gaps around GE.

The McGuinness report also calls for the implementation of all the recommendations made by the Royal Commission on Genetic Modification in 2001. Soil & Health has continued to ask for this. Many of the recommendations have never been carried out, such as adequate liability laws, or have been discontinued, like the Bioethics Council.

The risks of GE are too high, and our laws dont protect the public from financial liability when things go wrong. This is why local governments are moving to protect their communities, says Thomson.

This report should be required reading for all New Zealanders involved in decision-making about genetic engineering. This includes all levels of government, from central government agencies such as the Environmental Protection Agency and CRIs like AgResearch and Scion, to local governments.

The McGuinness Institute report points out the lack of investment value for New Zealanders in genetic engineering. Of the 57 field trials held here since 1988, Not one of these has resulted in any commercial benefit or tangible return on the publics investment, while all experiments have presented a constant risk.1

Soil & Health, established in 1941, is one of the worlds oldest organic organisations and publishes Organic NZ. We advocate for peoples right to have fresh, healthy, organic food and water free of GE, pesticides and additives. Oranga nuku, oranga kai, oranga tangata. http://organicnz.org.nz http://www.facebook.com/OrganicNZ

Reference 1. McGuinness, Wendy, and Mokena-Lodge, Renata, An Overview of Genetic Modification in New Zealand, 19732013: The first forty years, McGuinness Institute, Wellington, 29 August 2013 http://mcguinnessinstitute.org/includes/download.aspx?ID=130247

View post:
Think tank calls for GE-free farming

Recommendation and review posted by Bethany Smith

Published: September 03, 2013 6:00 AM

To the Editor,

At a Nanaimo City Council meeting Monday night, I heard speakers opposing genetically engineered foods, and one supporting them.

Former soil biologist Thierry Vrain, who worked for 30 years for Agriculture Canada as a genetic engineer, is well aware that genetic engineering is a very imprecise technology. He explained that when genetic engineering technology began, it was based on the theory that each gene codes for a single protein. But in 2002, the Human Genome Project was completed, making the old scientific paradigm obsolete. The new knowledge means that "every scientist now learns that any gene can give more than one protein, and that inserting a gene anywhere in a plant eventually creates rogue proteins. Some of these proteins are obviously allergenic or toxic."

Professor Robert Wager, who teaches at VIU and is a staunch supporter of GMO technology, told us there are no unintended consequences of GMO foods after 25 years. He has obviously not read a study completed in June of 2012 called GMO Myths and Truths, available for free online at Earth Open Source. He said there are no lawsuits being brought forth, but seems to be unaware of the fact that many US farmers are suing Monsanto whose GMO seeds are contaminating their non GMO crop fields. Mr. Wager continues to claim that "all of the alleged dangers of GM crops and food have been analyzed by global experts and dismissed." He also rejects research that demonstrates harm from GM crops and food as "pseudo-science," and boldly puts Dr. Vrain's research in that dismissive category.

It is not uncommon to find experts and authorities on both sides of a controversial issue. For such significant issues as the safety of our food supply and planetary environment, is it not appropriate to look at the integrity of the research, who is funding it, and who publishes it? In May of this year, a former Monsanto researcher joined the editorial staff of the journal Food and Chemical Toxicology. Such potential for conflict of interest, where one person can control or prevent the publication of research that would be inconvenient to the biotech industry, means that the public cannot trust peer-reviewed journals to reflect the true state of scientific knowledge. Add to this the well-known fact that scientists often choose to say yes to their research being funded by industry, a fact Dr. Vrain knows very well from being a member of the scientific community for 30 years.

On May 25 of this year, two million people from 52 countries marched against Monsanto, producer of 90 per cent of the world's genetically modified seed. They marched against a trans-national company having monopoly control of the world's food supply. Monsanto forces farmers who buy their seed to sign a contract stating they will not save seed. At a time when the world is focusing on food, it is time we realized that we have food today because farmers have saved seed every year for the next crop. In no way is forcing farmers to buy seed every year a sustainable practice.

If you care about the future of our food supply, I suggest to devote 90 minutes to watch the hard-hitting 2008 documentary, The World According to Monsanto, in which investigative journalist uncovers Monsanto's long track record of environmental crimes and health scandals. It is very important to understand that Monsanto is the same company that brought the world the toxins known as PCBs, dioxins and Agent Orange. Why in the name of everything we hold sacred should we trust the future of our food supply to this company?

Tsiporah Grignon Gabriola Island

Here is the original post:
GMO leaves sour taste

Recommendation and review posted by Bethany Smith

Public release date: 3-Sep-2013 [ | E-mail | Share ]

Contact: Vicki Cohn vcohn@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, NY, September 3, 2013A new recombinant antibody can detect and isolate mesenchymal stem cells (MSCs), a nonembryonic source of stem cells with promising applications in tissue engineering, blood stem cell transplantation, and treatments for immune-mediated disorders. The antibody recognizes an i blood group antigen present on MSCs in umbilical cord blood, as described in a study published in BioResearch Open Access, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the BioResearch Open Access website.

Tia Hirvonen and coauthors from the Finnish Red Cross Blood Service, Glykos Finland Ltd., and Biova Ltd. (Helsinki), and VTT Technical Research Center of Finland (Espoo), identified a blood donor with high levels of antibody to the i blood group antigen. No antibodies recognizing this antigen are commercially available at present.

In the article "Production of a Recombinant Antibody Specific for i Blood Group Antigen, a Mesenchymal Stem Cell Marker," the authors explain that the i antigen can serve as a marker to detect and isolate MSCs in umbilical cord blood (UCB). They describe the use of antibody phage display technology to produce a recombinant anti-i antibody that recognizes i antigen on the surface of UCB-MSCs as well as on red blood cells.

"The authors have used antibody phage display technology to generate an anti-i antibody," says BioResearch Open Access Editor Jane Taylor, PhD, MRC Centre for Regenerative Medicine, University of Edinburgh, Scotland. "The advantage of this technique is that antibodies against poorly immunogenic molecules can be generated, as an immunization strategy is not required. The availability of an anti-i antibody has the potential to improve the isolation efficiency of MSCs from umbilical cord blood samples."

###

About the Journal

BioResearch Open Access is a bimonthly peer-reviewed open access journal led by Editor-in-Chief Robert Lanza, MD, Chief Scientific Officer, Advanced Cell Technology, Inc. and Editor Jane Taylor, PhD. The Journal provides a new rapid-publication forum for a broad range of scientific topics including molecular and cellular biology, tissue engineering and biomaterials, bioengineering, regenerative medicine, stem cells, gene therapy, systems biology, genetics, biochemistry, virology, microbiology, and neuroscience. All articles are published within 4 weeks of acceptance and are fully open access and posted on PubMedCentral. All journal content is available on the BioResearch Open Access website.

About the Publisher

Read this article:
New recombinant antibody can isolate stem cells from umbilical cord blood

Recommendation and review posted by Bethany Smith

Published: Monday, September 2, 2013 at 11:49 p.m. Last Modified: Monday, September 2, 2013 at 11:49 p.m.

The 29-year-old Auburndale woman, a private nanny, represents one of the millions of U.S. consumers the Florida citrus industry will have to deal with if it takes the path of using genetically engineered trees as a solution to citrus greening, a fatal bacterial disease threatening commercial citrus production in the state.

Citrus growers are desperate for a long-term solution to greening, and most agree developing new trees tolerant or resistant to greening would be the best solution. But many in the Florida citrus community, fearing a consumer backlash from people such as Harp, question that scientists should pursue genetic engineering in breeding a greening-resistant tree.

Meanwhile, the debate continues with GMO supporters, including chemical and food companies and farmers who grow GMO crops, claiming there's no scientific proof the technology is unsafe. On the other side are people such as Harp with the support of some scientists who argue the GMO technology must be proven safe before its products are released into the marketplace.

Harp was one of the local organizers of the May 25 international "March Against Monsanto," the St. Louis-based company that is one of the leading producers of plants containing genetically modified organisms (GMOs). The Winter Haven march drew a few dozen people, she said.

Harp became an anti-GMO activist because of her 14-year struggle with an intestinal disorder that several doctors could not diagnose, she said. Beginning at age 14 and with increasing regularity into her 20s, Harp experienced debilitating intestinal inflammation that caused "excruciating pain" that kept her bed-ridden, sometimes for days.

She did not return to health until she eliminated meat, wheat, gluten, soy, dairy and most processed foods from her diet, Harp said.

Because many of those products have GMO ingredients, notably soy, Harp associates GMOs with her health problems. She also has religious and moral objections.

"I believe your body is a vessel. In order for your spirit and soul to be in the best shape it can be, you've got to take care of your body," Harp said. "I think it (genetic engineering) is wrong. When you genetically modify something by manipulating its genes, you create a mutant. You don't know what would happen to the human body."

Jan Allen, who runs Pat's Apiaries in Auburndale with husband Patrick, takes a more pragmatic stance against GMO foods.

Continued here:
Nature Vs. GMO: Sides Face Off Over Genetically Modified Food

Recommendation and review posted by Bethany Smith

Glendale, CA (PRWEB) September 03, 2013

Audio-Digest Foundation Announces the Release of Gastroenterology Volume 27, Issue 11: Celiac Disease.

The goal of this program is to improve the diagnosis and management of patients with celiac disease (CD). After hearing and assimilating this program, the clinician will be better able to:

1. Review the pathophysiology of CD 2. Assess the clinical manifestations of CD 3. Analyze the histologic findings associated with CD 4. Implement genetic and serologic testing for CD 5. Formulate a multidisciplinary management plan for patients diagnosed with CD

The original programs were presented by Dora M. Lam-Himlin, MD, Assistant Professor of Pathology and Senior Associate Consultant, Mayo Clinic, Arizona, Phoenix, and Joseph A. Murray, MD, Professor of Medicine, Consultant, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.

Audio-Digest Foundation, the largest independent publisher of Continuing Medical Education in the world, records over 10,000 hours of lectures every year in anesthesiology, emergency medicine, family practice, gastroenterology, general surgery, internal medicine, neurology, obstetrics/gynecology, oncology, ophthalmology, orthopaedics, otolaryngology, pediatrics, psychology, and urology, by the leading medical researchers at the top laboratories, universities, and institutions.

Recent researchers have hailed from Harvard, Cedars-Sinai, Mayo Clinic, UCSF, The University of Chicago Pritzker School of Medicine, The University of Kansas Medical Center, The University of California, San Diego, The University of Wisconsin School of Medicine, The University of California, San Francisco, School of Medicine, Johns Hopkins University School of Medicine, and many others.

Out of these cutting-edge programs, Audio-Digest then chooses the most clinically relevant, edits them for clarity, and publishes them either every week or every two weeks.

In addition, Audio-Digest publishes subscription series in conjunction with leading medical societies: DiabetesInsight with The American Diabetes Association, ACCEL with The American College of Cardiology, Continuum Audio with The American Academy of Neurology, and Journal Watch Audio General Medicine with Massachusetts Medical Society.

For 60 years, the global medical community of doctors, nurses, physician assistants, and other medical professionals around the world has subscribed to Audio-Digest specialty series in order to remain current in their specialties as well as to maintain their Continuing Education requirements with the most cutting-edge, independent, and unbiased continuing medical education (CME).

Continue reading here:
Audio-Digest Foundation Announces the Release of Gastroenterology Volume 27, Issue 11: Celiac Disease

Recommendation and review posted by Bethany Smith

Genetics problems 2 (dihybrid cross)
For more information, log on to- http://shomusbiology.weebly.com/ Download the study materials here- http://shomusbiology.weebly.com/bio-materials.html Genet...

By: Suman Bhattacharjee

Read the original here:
Genetics problems 2 (dihybrid cross) - Video

Recommendation and review posted by Bethany Smith

Let #39;s Play The Sims 3 - Perfect Genetics Challenge - Episode 26
My Sims 3 Page: http://mypage.thesims3.com/mypage/Llandros2012 My Blog: http://Llandros09.blogspot.com My Facebook: https://www.facebook.com/Llandros09?ref=t...

By: Llandros09

Link:
Let's Play The Sims 3 - Perfect Genetics Challenge - Episode 26 - Video

Recommendation and review posted by Bethany Smith

Local Search Results

You arrived here after searching for the following phrases:

Click a phrase to jump to the first occurrence, or return to the search results.

The first private Medical Genetics Center in Romania, an investment worth more than two million Euros, was launched in Bucharest yesterday, during the conference entitled Personalized Medicine New Prospects for the Romanian Patien, Agerpres informs. The Center is part of the World Map of Next Generation Sequencers, a world network including the centers that use high-capacity genomic sequencer platforms, it has four floors totalling 650 square meters and offers integrated services of examination and genetic testing. The Microarray NimbleGen platform equipping the Personal Genetics medical genetics center is yet another unique initiative in the Romanian private medical sector, with major use in the prenatal and postnatal diagnosis, said Dr Bogdanka Militescu, the Genetics Center managing director. The Center is structured by two departments, molecular biology and cyto-genetics respectively and it also offers genetic and psychological counselling. The expertise of the molecular biology department is divided into three categories of tests: diagnosis tests, genetic predisposition tests and pharma-genetic tests. The cyto-genetics department provides complex cyto-genetic diagnosis both for the prenatal diagnosis based on tests taken from chorionic villus, amniotic liquid, fetal blood, conceptive product as well as for the postnatal diagnosis from peripheral blood tests for the newborn babies, children or adults and from the haematogenous bone marrow in order to identify various types of leukemia. Also conducted at the Center are tests for identifying lung cancer, colon cancer, the hereditary breast- and ovary cancer risk, among others. Studies show that if the women having a breast cancer diagnosis made a genetic test before beginning treatment, there would be 34 percent less chemotherapy. Moreover, some 17,000 strokes could be prevented every year if a genetic test were made to assess the patients response to anti-coagulant therapy.

See more here:
First private medical genetics Center, launched in Bucharest

Recommendation and review posted by Bethany Smith

ITHACA, N.Y.--(BUSINESS WIRE)--

Vybion will present data on how its drug, INT41, alters a critical event in the development of Huntingtons disease at the 7th Neurodegenerative Conditions Research & Development Conference in Boston on September 9-10, 2013. INT41 is an Intrabody drug delivered by Gene Therapy that blocks gene dysregulation in Huntingtons Disease by neutralizing a toxic fragment of the Huntingtin mutant protein in the nucleus of the cell preventing gene dysregulation.

We are extremely excited by these data linking INT41 results to specific molecular events in Huntingtons pathology. INT41 provides a surgical approach to inactivate the event for which a growing body of evidence indicates occurs prior to symptoms and may be the driver of disease progression said Lee Henderson, Ph.D., the CEO of Vybion and a coauthor on the presentation. Vybion is pursuing the completion of preclinical development and expects to begin human clinical trials in the next 18 months.

About Vybion, Inc. Vybion is a development stage Company with proprietary technologies that form the core of our business strategy. Vybion uses proprietary technologies for Intrabody development to treat neurodegenerative diseases such as Huntington's, SBMA and SCA, and for target validation in signal transduction pathways and in multiple therapeutic areas. Vybion is advancing its novel research therapy for Huntingtons disease, INT41, through preclinical development with the aim of initiating clinical studies in the near future.

Read the original here:
Vybion’s Huntington Drug Neutralizes Critical Disease Driver

Recommendation and review posted by Bethany Smith

Spinal Cord Injury treated with Stem Cells
After the great response to Mrs. Bayer #39;s interview, we decided to publish another video revolving around one of our other patients named Imad. Please watch a...

By: Norbert Sass

Read more:
Spinal Cord Injury treated with Stem Cells - Video

Recommendation and review posted by sam

Adaptive devices at Madonna Rehab help young woman feel her best after spinal cord injury
Nineteen year-old Rachael Johnson sustained a paralyzing spinal cord injury, but that didn #39;t stop her daily beauty regimen. Rachael demonstrates how using ad...

By: MadonnaRehab

Read the original here:
Adaptive devices at Madonna Rehab help young woman feel her best after spinal cord injury - Video

Recommendation and review posted by sam

Adult Stem Cell Therapy for COPD: Stage-4 patient
Stage 4 COPD patient Ron Delkie arrived at the Regenerative Medicine Institute at Hospital Angeles Tijuana by ambulance, with very little hope of long term s...

By: nuehealth

Read more:
Adult Stem Cell Therapy for COPD: Stage-4 patient - Video

Recommendation and review posted by Bethany Smith

Cell Therapy Live - GOODIE MOB - AGE AGAINST THE MACHINE TO
I was so close for the stage monitors so the sound not as good in this video...BUT TRUST THE SHOW WAS INCREDIBLEEEEEE!!!!

By: Princess Black

More:
Cell Therapy Live - GOODIE MOB - AGE AGAINST THE MACHINE TO - Video

Recommendation and review posted by Bethany Smith

Goodie Mob Performs "Cell Therapy" at House of Blues For "Age Against The Machine"
Here #39;s more of that Good ole Goodie Mob, gettin down with yet another classic of that "Soul Food" Album. "Cell Therapy" was actually the first official singl...

By: sunofhollywood

See more here:
Goodie Mob Performs "Cell Therapy" at House of Blues For "Age Against The Machine" - Video

Recommendation and review posted by Bethany Smith

Stem Cell Therapy Day 0 -1 🙂
Montana starting to build new hips.

By: MoviesByMontana4Dogs

Read this article:
Stem Cell Therapy Day 0 -1 🙂 - Video

Recommendation and review posted by Bethany Smith

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/d8mv33/rna_mirna_rnai) has announced the addition of the "RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2013" report to their offering.

RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2013

Potentially any disease-causing gene, cell type or tissue can be targeted with miRNA, RNAi or siRNA, including those not 'druggable' with small molecules or protein-based therapies.

There are today 53 companies plus partners developing 79 RNA (miRNA, RNAi & siRNA) drugs in 110 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount to another 25 drugs. Rna (Mirna, Rnai & Sirna) Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 56 different targets. All included targets have been cross-referenced for the presence of mutations associated with human cancer. To date 41 out of the 41 studied drug targets so far have been recorded with somatic mutations. The software application lets you narrow in on these mutations and links out to the mutational analysis for each of the drug targets for detailed information. All drugs targets are further categorized on in the software application by 24 classifications of molecular function and with pathway referrals to BioCarta, KEGG, NCI-Nature and NetPath.

How May Drug Pipeline Update Be of Use?

- Show investors/board/management that you are right on top of drug development progress in your therapeutic area.

- Find competitors, collaborations partners, M&A candidates etc.

- Jump start competitive drug intelligence operations

- Excellent starting point for world wide benchmarking

- Compare portfolio and therapy focus with your peers

More:
Research and Markets: RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2013 Out Now for Review

Recommendation and review posted by Bethany Smith

Ive been selecting columns for a book of my favorites, written over the past 22 years for the editorial page of the Kennebec Journal and Waterville Morning Sentinel. I just came across this column about Gene Letourneau, published shortly after his funeral in 1998. I still miss Gene. How about you?

Gene Letourneaus last cast

The warm breeze wafting through Sacred Heart Church in Waterville last Thursday surely must have carried Gene Letourneaus spirit to the great hunting ground beyond our imagination.

As expected, Letourneaus funeral featured stories about fly fishing and hunting dogs, but we also heard about his musical talent, faith in God, and devotion to his family, especially his lovely wife Lou who died in 1996. The light went out for Gene then, and he began his own hike to join Lou. Hes there now, sipping that Heavenly cold clear spring water.

We are bereft, for the irreplaceable outdoor writer has left behind his canoe without so much as a wake we can ride for even a short way. His paddle dipped too quietly, I guess, for his bosses to realize the impact he was having on the people of Maine, his devoted readers and correspondents.

Genes daily outdoors column, titled Sportsmen Say, that started my day as a kid, is gone, found in none of todays daily newspapers, still wondering why theyre losing subscribers.

I was privileged to appear in a video of reverence and praise presented to Gene at his spectacular retirement party at the Augusta Civic Center a few years ago. My remarks focused on the real magic of his newspaper column, in the section called Chips from the blazed trail.

It was here that Gene presented first-hand reports he received in letters and phone calls from sportsmen throughout the state, accounts of their exciting adventures, latest fishing successes, hunting prowess or simple observations of wild birds and animals.

I always felt this was the secret of his column: he let the voices of his readers and fans be heard. Sportsmen Say. Indeed.

Gene connected with people, whether or not they shared his passion for hunting and fishing, because he presented Maines outdoor traditions in their own words, kept them informed, shared his extensive knowledge (while keeping some secret ponds to himself to protect those precious resources), always in simple, clear prose.

Read more:
Gene Letourneau’s Last Cast

Recommendation and review posted by Bethany Smith

Home Mail News Sports Finance Weather Games Groups Answers Flickr More omg! Shine Movies Music TV Health Shopping Travel Autos Homes Mobile Yahoo! News Search News Search Web Sign In Mail Help Account Info Help Suggestions Yahoo! Home Video Photos GMA Year in Review Odd Comics Travel Opinion Trending Now Who Knew? Weather The Upbeat U.S. U.S. Video GMA Education Religion Crimes and Trials Local Contributor Network Year In Review World World Video Middle East Europe Latin America Africa Asia Canada Australia/Antarctica Business Video Exclusives Today's Markets Stocks Personal Finance Marketplace Entertainment Video Clinton Concert Celebrity TV Movies Music Fashion Books Arts Theater Dear Abby Comics Odd News Sports Video NFL MLB NBA NCAAF NCAAB Soccer Cycling NHL Tennis Golf Boxing Motor Sports MMA Olympics Tech Gadgets Wireless Apple Social Media Security Open Source Gaming Apps This Could Be Big Upgrade Your Life Politics Remake America The Issues Women and Politics Press Releases Video Science Science Video Weather News Space / Astronomy Pets Dinosaurs / Fossils Biotech Energy Green Health Video Weight Loss Cancer Sexual Health Medications/Drugs Parenting/Kids Seniors/Aging Diseases/Conditions Blogs The Sideshow Katie's Take Power Players This Could Be Big Newsmakers Trending Now The Upbeat Who Knew? Nightline Fix Beyond the Headline Local Popular Search Keyword News Search

Read the rest here:
Time to stop fighting GMO labeling?

Recommendation and review posted by Bethany Smith

Advanced Genetics and Team Green Athlete Josee Gallant
Contest Prep, Rep #39;n Advanced Genetics and Team Green I do not own the rights to the music heard in this video. It belongs to the respective copyright owners....

By: Jason Green

Here is the original post:
Advanced Genetics and Team Green Athlete Josee Gallant - Video

Recommendation and review posted by Bethany Smith

The Sims 3: Perfect Genetics Challenge: Episode 4
Baljeet.

By: ThePenguinExpress

Continue reading here:
The Sims 3: Perfect Genetics Challenge: Episode 4 - Video

Recommendation and review posted by Bethany Smith

The Sims 3: Perfect Genetics Challenge: Episode 5
Im lazy as hell.

By: ThePenguinExpress

Read more from the original source:
The Sims 3: Perfect Genetics Challenge: Episode 5 - Video

Recommendation and review posted by Bethany Smith

RACING PIGEON TIPS 2 ....... TRICKS OF THE TRADE
AFTER MY FIRST VIDEO OF THE SECRECTS CHAMPIONS KNOW ,THERE WAS A VERY BIG POSITIVE RESPONSE AND I DID A FOLLOW UP .. SEE superacepigeon.weebly.com . WHAT TO ...

By: wynand wolmarans

Visit link:
RACING PIGEON TIPS 2 ....... TRICKS OF THE TRADE - Video

Recommendation and review posted by Bethany Smith

Pitch Nim Genetics SSIS 2012
Presentación Nim Genetics durante la edición 2012 de Spain Startup Investor Summit.

By: SpainStartUp

Go here to read the rest:
Pitch Nim Genetics SSIS 2012 - Video

Recommendation and review posted by Bethany Smith

Genetics and Care for Children with Congenital Heart Defects
The "Genetics and Care for Children with Congenital Heart Defects" seminar was presented by Dr. John Belmont and Susan Fernbach, RN, BSN on Aug. 1, 2013. This is part of the Evenings with Genetics...

By: BCMweb

See the original post here:
Genetics and Care for Children with Congenital Heart Defects - Video

Recommendation and review posted by Bethany Smith